STOXX 50 price at the end of trading.
The STOXX 50 ultimately trended 0.33 percent lower in STOXX trading at 4,285.56 points. Previously, the STOXX 50 started trading 0.013 percent lighter at 4,299.38 points, after 4,299.92 points the previous day.
The STOXX 50 recorded a daily low of 4,283.39 points. The daily high today was 4,301.67 units.
This is how the STOXX 50 develops over the course of the year
The STOXX 50 has already lost 0.432 percent since the beginning of the week. A month ago, STOXX trading was suspended for the weekend. On the previous trading day, January 26, 2024, the STOXX 50 had 4,193.32 points. The STOXX 50 had a level of 3,943.07 points three months ago, on November 28, 2023. A year ago, on February 28, 2023, the STOXX 50 was at 3,895.48 points.
Since the beginning of 2024, the index has already increased by 4.73 percent. The STOXX 50 recorded its highest value this year at 4,317.04 points. The annual low, however, was reached at 4,010.21 points.
The tops and flops in the STOXX 50
The top stocks in the STOXX 50 currently include Siemens (+ 1.83 percent to EUR 179.86), Mercedes-Benz Group (ex Daimler) (+ 1.72 percent to EUR 73.40), Zurich Insurance (+ 1.16 percent to 470.40 CHF), Richemont (+ 1.13 percent to 138.55 CHF) and DHL Group (ex Deutsche Post) (+ 0.83 percent to 43.19 EUR). In the STOXX 50, however, Reckitt Benckiser (-13.29 percent to 50.62 GBP), Bayer (-1.97 percent to 28.56 EUR), Nestlé (-1.74 percent to 92.05 CHF), are under pressure. SAP SE (-1.53 percent to EUR 172.12) and AstraZeneca (-1.43 percent to GBP 101.80).
The most expensive STOXX 50 companies
The BP share currently has the largest trading volume in the STOXX 50. 25,380,337 shares were last traded via STOXX. With a market capitalization of 504.836 billion euros, the Novo Nordisk share currently has the highest market value in the STOXX 50.
Fundamentals of STOXX 50 stocks
According to FactSet estimates, Bayer shares have the lowest price-earnings ratio (P/E) in the STOXX 50 this year. A P/E ratio of 5.24 should be recorded here. According to FactSet estimates, HSBC shares are expected to have the most attractive dividend yield of 10.40 percent in 2024 among the stocks in the index.
Editorial team finanzen.net
Selected leveraged products on AstraZeneca
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on AstraZeneca
The leverage must be between 2 and 20
Advertising